Ticker Details
FibroGen, Inc FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.
IPO Date:	November 14, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$39.28M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.61 | 3.04%
Avg Daily Range (30 D):	$0.30 | 3.25%
Avg Daily Range (90 D):	$0.23 | 2.44%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	M
Avg Daily Volume (90 D):	.02M

Trade Size
Avg Trade Size (Sh.):	34
Avg Trade Size (Sh.) (30 D):	145
Avg Trade Size (Sh.) (90 D):	104

Institutional Trades
Total Institutional Trades:	4,004
Avg Institutional Trade:	$2.19M
Avg Institutional Trade (30 D):	$.67M
Avg Institutional Trade (90 D):	$.67M
Avg Institutional Trade Volume:	M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.9M
Avg Closing Trade (30 D):	$9.03M
Avg Closing Trade (90 D):	$9.03M
Avg Closing Volume:	4.91K

News

Aug 18, 2025 @ 11:00 AM FibroGen Announces Approval of Sale of FibroGen Ch... Source: Fibrogen, Inc.

Feb 20, 2025 @ 6:08 PM Amid Mounting Pressure In China, AstraZeneca Buys ... Source: Vandana Singh

Sep 2, 2024 @ 8:15 PM Liver Fibrosis Market Is Expected to Reach USD 43.... Source: The Brainy Insights

Aug 23, 2024 @ 10:04 PM Catalyst Accelerator Ogden Selects 11 Companies fo... Source: Catalyst Accelerator Ogden

Jun 3, 2024 @ 8:48 PM FibroGen Stock Is Surging After The Bell: What's G... Source: Adam Eckert

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$64.85	$49.61	$-1.88
Diluted EPS	$64.85	$49.61	$-1.88
Revenue	$8.3M	$1.08M	$1.35M
Gross Profit	$13.87M	$1.13M	$1.26M
Net Income / Loss	$215.65M	$200.64M	$-7.6M
Operating Income / Loss	$-39.52M	$-5.41M	$-12.05M
Cost of Revenue	$-5.57M	$-.06M	$.09M
Net Cash Flow	$48.68M	$-.6M	$12.66M
PE Ratio

Splits
Jun 17, 2025	1:25